[HTML][HTML] Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: a systematic review

BO Okusanya, IO Asaolu, JE Ehiri, LJ Kimaru… - Systematic reviews, 2020 - Springer
Background Medical cannabis (MC) is currently being used as an adjunct to opiates given
its analgesic effects and potential to reduce opiate addiction. This review assessed if MC …

Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: a systematic review.

BO Okusanya, IO Asaolu, JE Ehiri, LJ Kimaru… - Systematic …, 2020 - europepmc.org
Background Medical cannabis (MC) is currently being used as an adjunct to opiates given
its analgesic effects and potential to reduce opiate addiction. This review assessed if MC …

[HTML][HTML] Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: a systematic review

BO Okusanya, IO Asaolu, JE Ehiri, LJ Kimaru… - Systematic …, 2020 - ncbi.nlm.nih.gov
Background Medical cannabis (MC) is currently being used as an adjunct to opiates given
its analgesic effects and potential to reduce opiate addiction. This review assessed if MC …

Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: A systematic review

B Okusanya, IO Asaolu, JE Ehiri, LJ Kimaru… - 2020 - researchsquare.com
Background: Medical cannabis (MC) is currently being used as an adjunct to opiates given
its analgesic effects and potential to reduce opiate addiction. This review assessed if MC …

[HTML][HTML] Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: a systematic review

BO Okusanya, IO Asaolu, JE Ehiri… - Systematic …, 2020 - systematicreviewsjournal …
Medical cannabis (MC) is currently being used as an adjunct to opiates given its analgesic
effects and potential to reduce opiate addiction. This review assessed if MC used in …

Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: a systematic review

BO Okusanya, IO Asaolu, JE Ehiri… - Systematic …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Medical cannabis (MC) is currently being used as an adjunct to opiates given
its analgesic effects and potential to reduce opiate addiction. This review assessed if MC …

Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: a systematic review.

BO Okusanya, IO Asaolu, JE Ehiri, LJ Kimaru… - Systematic …, 2020 - go.gale.com
Background Medical cannabis (MC) is currently being used as an adjunct to opiates given
its analgesic effects and potential to reduce opiate addiction. This review assessed if MC …

Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: a systematic review.

BO Okusanya, IO Asaolu, JE Ehiri, LJ Kimaru… - 2020 - cabidigitallibrary.org
Background: Medical cannabis (MC) is currently being used as an adjunct to opiates given
its analgesic effects and potential to reduce opiate addiction. This review assessed if MC …

Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: a systematic review

BO Okusanya, IO Asaolu, JE Ehiri… - Systematic …, 2020 - search.proquest.com
Background Medical cannabis (MC) is currently being used as an adjunct to opiates given
its analgesic effects and potential to reduce opiate addiction. This review assessed if MC …

[PDF][PDF] Medical cannabis for the reduction of opioid dosage in the treatment of non-cancer chronic pain: a systematic review

BO Okusanya, IO Asaolu, JE Ehiri, LJ Kimaru… - 2020 - greenleafmc.ca
Background: Medical cannabis (MC) is currently being used as an adjunct to opiates given
its analgesic effects and potential to reduce opiate addiction. This review assessed if MC …